- Home
- MUX vs TSHA Comparison
MUX vs TSHA Comparison
Compare MUX & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- TSHA
- Stock Information
- Founded
- MUX 1979
- TSHA 2019
- Country
- MUX Canada
- TSHA United States
- Employees
- MUX N/A
- TSHA N/A
- Industry
- MUX Precious Metals
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- TSHA Health Care
- Exchange
- MUX Nasdaq
- TSHA Nasdaq
- Market Cap
- MUX 423.9M
- TSHA 356.7M
- IPO Year
- MUX N/A
- TSHA 2020
- Fundamental
- Price
- MUX $6.63
- TSHA $1.23
- Analyst Decision
- MUX Strong Buy
- TSHA Strong Buy
- Analyst Count
- MUX 2
- TSHA 8
- Target Price
- MUX $15.25
- TSHA $6.63
- AVG Volume (30 Days)
- MUX 986.4K
- TSHA 2.4M
- Earning Date
- MUX 03-18-2025
- TSHA 05-13-2025
- Dividend Yield
- MUX N/A
- TSHA N/A
- EPS Growth
- MUX N/A
- TSHA N/A
- EPS
- MUX N/A
- TSHA N/A
- Revenue
- MUX $174,477,000.00
- TSHA $8,333,000.00
- Revenue This Year
- MUX $36.24
- TSHA N/A
- Revenue Next Year
- MUX N/A
- TSHA N/A
- P/E Ratio
- MUX N/A
- TSHA N/A
- Revenue Growth
- MUX 4.96
- TSHA N/A
- 52 Week Low
- MUX $6.46
- TSHA $1.17
- 52 Week High
- MUX $12.50
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- MUX 37.68
- TSHA 32.19
- Support Level
- MUX $7.19
- TSHA $1.17
- Resistance Level
- MUX $7.54
- TSHA $1.87
- Average True Range (ATR)
- MUX 0.38
- TSHA 0.17
- MACD
- MUX -0.07
- TSHA -0.06
- Stochastic Oscillator
- MUX 1.32
- TSHA 5.77
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.